CA
CELG

Cortland Associates’s Celgene Corp CELG Stock Holding History

Cortland Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,790
Closed -$261K – 54
2017
Q3 		$261K Hold
1,790
– – 0.05% 43
2017
Q2 		$232K Hold
1,790
– – 0.04% 45
2017
Q1 		$223K Hold
1,790
– – 0.05% 48
2016
Q4 		$207K Buy
+1,790
New +$199K 0.04% 49
2016
Q1 		– Sell
-1,870
Closed -$224K – 44
2015
Q4 		$224K Sell
1,870
-30
-2% -$3.47K 0.04% 39
2015
Q3 		$206K Hold
1,900
– – 0.05% 36
2015
Q2 		$220K Hold
1,900
– – 0.05% 33
2015
Q1 		$219K Hold
1,900
– – 0.05% 34
2014
Q4 		$213K Buy
+1,900
New +$200K 0.04% 34

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cortland Associates's CELG Position: Q4 2017 in Review

Cortland Associates sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,790 shares — an estimated $261K sold.

Cortland Associates first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $261K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Cortland Associates reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Cortland Associates sold 1,790 Celgene Corp shares in Q4 2017, an estimated $261K.
  • Cortland Associates first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
  • Cortland Associates's Celgene Corp position peaked at $261K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Cortland Associates's 13F filing for Q4 2017, filed 24 Jan 2018.